Cargando…

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients

PURPOSE: Warfarin is an oral anticoagulant associated with adverse reaction to drugs due to wide inter- and intra-individual dosage variability. Warfarin dosage has been related to non-genetic and genetic factors. CYP2C9 and VKORC1 gene polymorphisms affect warfarin metabolism and dosage. Due to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galvez, Jubby Marcela, Restrepo, Carlos Martin, Contreras, Nora Constanza, Alvarado, Clara, Calderón-Ospina, Carlos-Alberto, Peña, Nidia, Cifuentes, Ricardo A, Duarte, Daniela, Laissue, Paul, Fonseca, Dora Janeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198877/ https://www.ncbi.nlm.nih.gov/pubmed/30410385 http://dx.doi.org/10.2147/PGPM.S170515

Ejemplares similares

Possible Genetic Determinants of Response to Phenytoin in a Group of Colombian Patients With Epilepsy
por: Calderon-Ospina, Carlos Alberto, et al.
Publicado: (2020)

Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population
por: Ramírez, Brian, et al.
Publicado: (2019)

A first description of the Colombian national registry for rare diseases
por: Mateus, Heidi Eliana, et al.
Publicado: (2017)

A Pharmacogenetic Study of CYP2C19 in Acute Coronary Syndrome Patients of Colombian Origin Reveals New Polymorphisms Potentially Related to Clopidogrel Therapy
por: Angulo-Aguado, Mariana, et al.
Publicado: (2021)

Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing
por: Silgado-Guzmán, Daniel Felipe, et al.
Publicado: (2022)

Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans
por: Steiner, Heidi E., et al.
Publicado: (2021)

Lack of association of polymorphisms in six candidate genes in colombian adhd patients
por: Fonseca, Dora J, et al.
Publicado: (2015)

Ocular findings in Fabry disease in Colombian patients
por: Rothstein, Katherine, et al.
Publicado: (2019)

Association Between the LZTFL1 rs11385942 Polymorphism and COVID-19 Severity in Colombian Population
por: Angulo-Aguado, Mariana, et al.
Publicado: (2022)

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)

Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009)

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions
por: Calderon-Ospina, Carlos Alberto, et al.
Publicado: (2020)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Warfarin pharmacogenetics: How close are we to clinical practice?
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Warfarin Dosage Response Related Pharmacogenetics in Chinese Population
por: Li, Siyue, et al.
Publicado: (2015)

Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
por: Liu, Rong, et al.
Publicado: (2015)

The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort
por: Al Ammari, Maha, et al.
Publicado: (2020)

Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations
por: Parada-Márquez, Juan Fernando, et al.
Publicado: (2023)

Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy
por: Triana-Fonseca, Paula, et al.
Publicado: (2021)

Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2009)

Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model
por: Mazzaccara, Cristina, et al.
Publicado: (2013)

Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm
por: Pei, Lin, et al.
Publicado: (2018)

Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina
por: Ašić, Adna, et al.
Publicado: (2019)

Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2021)

A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients
por: Chen, Jinxing, et al.
Publicado: (2014)

A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics
por: Duconge, Jorge, et al.
Publicado: (2016)

Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
por: Chang, Grace Shu-wen, et al.
Publicado: (2020)

Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population
por: Ren, Yirong, et al.
Publicado: (2020)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
por: Roche-Lima, Abiel, et al.
Publicado: (2020)

Performance Comparison of a Duplex Implementation of the CDC EUA 2019-nCoV Assay with the Seegene Allplex-SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Nasopharyngeal Swab Samples
por: Jiménez, Karen Marcela, et al.
Publicado: (2022)

Epidemiology and Toxicology of Ciguatera Poisoning in the Colombian Caribbean
por: Navarro Quiroz, Roberto, et al.
Publicado: (2020)

Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population
por: Corredor-Orlandelli, David, et al.
Publicado: (2021)

Characterization of sexually transmitted infections, their pharmacological treatment, and recurrence in a Colombian population
por: Valladales-Restrepo, Luis Fernando, et al.
Publicado: (2021)

Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)
por: Branco, Claudia C, et al.
Publicado: (2009)

Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms
por: Hamberg, Anna-Karin, et al.
Publicado: (2013)

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation
por: Pengo, Vittorio, et al.
Publicado: (2015)

Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials
por: Shi, Changcheng, et al.
Publicado: (2015)

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study
por: Gemmati, Donato, et al.
Publicado: (2016)

Profiling of warfarin pharmacokinetics‐associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics‐dosing algorithm
por: Ndadza, Arinao, et al.
Publicado: (2021)

CC8 MRSA Strains Harboring SCCmec Type IVc are Predominant in Colombian Hospitals
por: Jiménez, J. Natalia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_be65aqqqg6d1rc7536qhopqgv9